When asked about 'our exit cases' in an Integral interview, one that can be discussed alongside the listing of Tessend ...
Darling Ingredients' third quarter results were met with a negative market reaction as the company missed Wall Street’s revenue expectations and reported a significant shortfall in adjusted EBITDA.
Kyorin Pharmaceutical is currently in the process of restructuring its corporate form. In May 2026, it released a new ...